rs62487918
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001374258.1(BRAF):c.1638-48C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0703 in 1,592,052 control chromosomes in the GnomAD database, including 4,469 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 289 hom., cov: 32)
Exomes 𝑓: 0.072 ( 4180 hom. )
Consequence
BRAF
NM_001374258.1 intron
NM_001374258.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0310
Publications
8 publications found
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- cardiofaciocutaneous syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P, Genomics England PanelApp
- LEOPARD syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- Noonan syndrome 7Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, Genomics England PanelApp
- Noonan syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
- anaplastic astrocytomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 7-140777136-G-A is Benign according to our data. Variant chr7-140777136-G-A is described in ClinVar as Benign. ClinVar VariationId is 40378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRAF | ENST00000644969.2 | c.1638-48C>T | intron_variant | Intron 13 of 19 | NM_001374258.1 | ENSP00000496776.1 | ||||
BRAF | ENST00000646891.2 | c.1518-48C>T | intron_variant | Intron 12 of 17 | NM_004333.6 | ENSP00000493543.1 |
Frequencies
GnomAD3 genomes AF: 0.0568 AC: 8625AN: 151816Hom.: 288 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8625
AN:
151816
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0703 AC: 17371AN: 247080 AF XY: 0.0761 show subpopulations
GnomAD2 exomes
AF:
AC:
17371
AN:
247080
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0718 AC: 103337AN: 1440134Hom.: 4180 Cov.: 28 AF XY: 0.0740 AC XY: 53110AN XY: 717382 show subpopulations
GnomAD4 exome
AF:
AC:
103337
AN:
1440134
Hom.:
Cov.:
28
AF XY:
AC XY:
53110
AN XY:
717382
show subpopulations
African (AFR)
AF:
AC:
609
AN:
32974
American (AMR)
AF:
AC:
1562
AN:
44312
Ashkenazi Jewish (ASJ)
AF:
AC:
2775
AN:
25954
East Asian (EAS)
AF:
AC:
3297
AN:
39538
South Asian (SAS)
AF:
AC:
9691
AN:
85614
European-Finnish (FIN)
AF:
AC:
3148
AN:
53192
Middle Eastern (MID)
AF:
AC:
704
AN:
5666
European-Non Finnish (NFE)
AF:
AC:
77134
AN:
1093258
Other (OTH)
AF:
AC:
4417
AN:
59626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4818
9636
14453
19271
24089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2906
5812
8718
11624
14530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0568 AC: 8624AN: 151918Hom.: 289 Cov.: 32 AF XY: 0.0576 AC XY: 4273AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
8624
AN:
151918
Hom.:
Cov.:
32
AF XY:
AC XY:
4273
AN XY:
74216
show subpopulations
African (AFR)
AF:
AC:
938
AN:
41468
American (AMR)
AF:
AC:
811
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
360
AN:
3466
East Asian (EAS)
AF:
AC:
437
AN:
5162
South Asian (SAS)
AF:
AC:
552
AN:
4816
European-Finnish (FIN)
AF:
AC:
617
AN:
10454
Middle Eastern (MID)
AF:
AC:
32
AN:
288
European-Non Finnish (NFE)
AF:
AC:
4716
AN:
67970
Other (OTH)
AF:
AC:
127
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
418
837
1255
1674
2092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
325
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.